What are the recommended dosing regimens for second‑generation cephalosporins in adults and children?

Second-Generation Cephalosporin Dosing Regimens

Adult Dosing

For surgical prophylaxis and most infections in adults, second-generation cephalosporins should be dosed as follows: cefazolin 1 g IV every 8 hours, cefuroxime 500 mg PO every 12 hours or 1.5 g IV every 8-12 hours, cefoxitin 1-2 g IV every 8 hours, and cefprozil 500 mg PO every 12 hours. 1

Specific Adult Indications

• Urologic surgical prophylaxis: Cefazolin 1 g IV every 8 hours is the standard second-generation option, though it is technically classified as first-generation 1
• Intra-abdominal infections (mild-to-moderate): Cefuroxime, ceftriaxone, or cefotaxime combined with metronidazole are recommended as combination therapy 2
• Orthopedic prophylaxis with joint replacements: Single-dose regimens of ciprofloxacin 500 mg, levofloxacin 500 mg, or ofloxacin 400 mg orally 1-2 hours preoperatively, or ampicillin 2 g IV plus gentamicin 1.5 mg/kg IV 30-60 minutes preoperatively 1

Important Adult Dosing Considerations

• Prolonged surgical procedures: Repeat intraoperative dosing may be needed sooner than standard intervals, particularly for agents with shorter half-lives 1
• Single-dose prophylaxis: For most surgical procedures, a single dose after anesthesia induction is sufficient, with a second dose only if surgery is delayed or prolonged 3, 4
• Postoperative administration: Continuing antibiotics postoperatively is unnecessary and potentially harmful 4

Pediatric Dosing

For febrile infants and children with bacterial infections, ceftriaxone 50-100 mg/kg/day IV is the most commonly recommended second/third-generation cephalosporin, with dosing frequency and specific agents varying by age and infection site. 5

Age-Stratified Pediatric Dosing

Neonates and young infants (8-21 days old):

• UTI or no identified focus: Ampicillin 150 mg/kg/day IV divided every 8 hours PLUS either ceftazidime 150 mg/kg/day IV divided every 8 hours OR gentamicin 4 mg/kg IV every 24 hours 5
• Bacterial meningitis: Ampicillin 300 mg/kg/day IV divided every 6 hours PLUS ceftazidime 150 mg/kg/day IV divided every 8 hours 5

Infants 22-28 days old:

• UTI or no identified focus: Ceftriaxone 50 mg/kg IV every 24 hours 5
• Bacterial meningitis: Ampicillin 300 mg/kg/day IV divided every 6 hours PLUS ceftazidime 150 mg/kg/day IV divided every 8 hours 5

Infants and children 29-60 days old:

• UTI: Ceftriaxone 50 mg/kg IV every 24 hours, OR oral cephalexin 50-100 mg/kg/day in 4 doses or cefixime 8 mg/kg/day in 1 dose for infants >28 days 5
• No identified focus: Ceftriaxone 50 mg/kg IV every 24 hours 5
• Bacterial meningitis: Ceftriaxone 100 mg/kg/day IV once daily or divided every 12 hours OR ceftazidime 150 mg/kg/day IV divided every 8 hours PLUS vancomycin 60 mg/kg/day IV divided every 8 hours 5

Pediatric Dosing for Specific Infections

Intra-abdominal infections in children:

• Mild-to-moderate: Cefotaxime, ceftriaxone, ceftazidime, or cefepime combined with metronidazole 2
• Community-acquired pneumonia: Second-generation oral cephalosporins like cefuroxime 30 mg/kg/day divided twice daily for 10 days 6, 7

Multidrug-resistant organism infections (from specialized guidelines):

• Cefepime: Neonates <36 weeks gestational age: 30 mg/kg IV every 12 hours; ≥36 weeks: 50 mg/kg IV every 12 hours; children: 50 mg/kg IV every 8 hours (max 2000 mg/dose) 8
• Ceftazidime: Neonates <32 weeks and <14 days: 50 mg/kg IV every 12 hours; ≥32 weeks and >7 days: 50 mg/kg IV every 8 hours; children: 200-300 mg/kg/day IV in 3 divided doses for serious Pseudomonas infections (max 12,000 mg/day) 8

Key Clinical Considerations

Spectrum Limitations

• Second-generation cephalosporins have reduced activity against gram-positive cocci compared to first-generation agents but improved gram-negative coverage 9
• Cefuroxime is the most active cephalosporin against beta-lactamase-producing Haemophilus influenzae 9
• These agents generally do not cover MRSA, most enterococci, Pseudomonas spp., Acinetobacter spp., or penicillin-resistant S. pneumoniae 10

Resistance Concerns

• Exposure to second-generation cephalosporins increases future resistance to all cephalosporins, with the highest increase in resistance to the same antibiotic class 11
• In nosocomial settings, third-generation cephalosporin resistance is significantly higher (54.3% vs 33.8% in community-acquired infections), making empiric second-generation therapy less reliable 12
• For community-acquired infections, second-generation cephalosporins remain effective when local resistance patterns show low rates of resistance 12

Comparative Efficacy

• No significant difference in wound infection rates between cefazolin (first-generation) and cefuroxime (second-generation) in cardiac surgery prophylaxis (2.1% vs 2.9%, p=0.79) 13
• Amoxicillin, cefuroxime, and ceftriaxone show equivalent clinical efficacy in pediatric acute otitis media, though single-dose ceftriaxone offers administration advantages 7
• Second-generation cephalosporins provide appropriate perioperative prophylaxis for procedures requiring coverage of Staphylococcus spp., Streptococcus spp., and E. coli at doses of 1.5-2 g 3